Capstone Therapeutics Corp. (CAPS)

US — Healthcare Sector
Peers: PXMD  JAGX  PARD  VIAP  XHLD  AFFY  ARYX 

Automate Your Wheel Strategy on CAPS

With Tiblio's Option Bot, you can configure your own wheel strategy including CAPS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol CAPS
  • Rev/Share 836.4913
  • Book/Share 519.6666
  • PB 0.0023
  • Debt/Equity 0.7324
  • CurrentRatio 1.1399
  • ROIC -0.0322

 

  • MktCap 6671826.0
  • FreeCF/Share 54.4675
  • PFCF 2.36
  • PE -0.0163
  • Debt/Assets 0.3784
  • DivYield 0
  • ROE -0.7373

 

  • Rating B-
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 5
  • P/B Score 5
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

Capstone Reports Q2 2025 Results: Gross Margin Up to 24.4%; First Acquisition Nears Close
CAPS
Published: August 15, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / August 15, 2025 / Capstone Holding Corp. (NASDAQ:CAPS) today announced its second quarter 2025 financial results and strategic highlights, including substantial gross margin expansion and that it has executed an agreement today that it expects to close in the next 10 days for its first acquisition. The acquisition of a Carolina Based Stone Company will be immediately accretive and extend the company's reach into the high-growth Southeast market and expand Instone's distribution platform.

Read More
image for news Capstone Reports Q2 2025 Results: Gross Margin Up to 24.4%; First Acquisition Nears Close
Capstone Secures Up To $10 Million Financing Facility - Supports Acquisition Strategy
CAPS
Published: July 30, 2025 by: Accesswire
Sentiment: Neutral

Initial $3 Million Close Facilitates Announced Southeast, U.S. Based Deal Under LOI NEW YORK CITY, NEW YORK / ACCESS Newswire / July 30, 2025 / Capstone Holding Corp. (NASDAQ:CAPS), a national building products distribution platform, today announced the closing of a $10 million convertible note facility on July 29, 2025, which will be initially used to provide valuable additional financing capacity to support its previously announced M&A strategy. It has drawn down $3 million of the facility and may access the remaining capital on terms to be mutually agreed.

Read More
image for news Capstone Secures Up To $10 Million Financing Facility - Supports Acquisition Strategy
Capstone Holding Corp. (NASDAQ:CAPS), Secures $1 Million Pangaea Stone Order in Expanding Territory
CAPS
Published: June 17, 2025 by: Accesswire
Sentiment: Neutral

Highlights new project in Mountain States, marking major growth milestone ALSIP, IL / ACCESS Newswire / June 17, 2025 / Capstone Holding Corp. (NASDAQ:CAPS) today announced that its Instone subsidiary secured a $1 million order for Pangaea® Natural Stone as part of a luxury resort development in the Mountain States. The company has already delivered $200,000 in shipments, marking successful entry into this high-value regional market.

Read More
image for news Capstone Holding Corp. (NASDAQ:CAPS), Secures $1 Million Pangaea Stone Order in Expanding Territory

About Capstone Therapeutics Corp. (CAPS)

  • IPO Date 1993-01-28
  • Website https://www.capstonethx.com
  • Industry Biotechnology
  • CEO Matthew E. Lipman
  • Employees 36

Capstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs that have completed Phase Ia and Phase Ib/IIa clinical trials for lipoprotein metabolism. The company was formerly known as OrthoLogic Corp. and changed its name to Capstone Therapeutics Corp. in May 2010. Capstone Therapeutics Corp. was founded in 1987 and is headquartered in Tempe, Arizona.